サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1697136

臨床試験イメージングの世界市場：業界分析、規模、シェア、成長、動向、予測（2025年～2032年）

Clinical Trial Imaging Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

出版日
ページ情報
英文 250 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
臨床試験イメージングの世界市場：業界分析、規模、シェア、成長、動向、予測（2025年～2032年）
出版日: 2025年03月31日
発行: Persistence Market Research
ページ情報: 英文 250 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の臨床試験イメージングの市場規模は、2025年に15億米ドルになるとみられ、2025年～2032年の予測期間に7.5%のCAGRで拡大し、2032年には25億米ドルに達すると予測されています。

臨床試験イメージングとは、新薬、治療、医療機器の有効性と安全性を評価するための臨床試験において、MRI、CTスキャン、PETスキャン、超音波などの医療イメージング技術を使用することを指します。これらの画像モダリティは、研究者の正確な疾病診断、治療モニタリング、バイオマーカー同定に役立っています。製薬企業やバイオテクノロジー企業は、規制当局の承認をサポートし、医薬品開発期間を短縮するために、画像に基づくエビデンスへの依存度を高めているため、臨床試験用画像の需要は増加しています。

世界の臨床試験イメージング市場は、臨床研究における高度なイメージング技術の採用拡大など、いくつかの重要な要因によって牽引されています。がん、心血管疾患、神経疾患などの慢性疾患の有病率の上昇が、医薬品臨床試験における画像ベースのバイオマーカーの需要を促進しています。さらに、世界の臨床試験件数の増加とイメージングエンドポイントに対する厳しい規制要件が相まって、市場成長を後押ししています。人工知能（AI）および機械学習（ML）とイメージング技術の統合の進歩は、画像解析の精度をさらに高め、臨床試験の成果を向上させています。

大きな成長機会にもかかわらず、臨床試験イメージング市場は、画像モダリティやインフラに関連する高コストなどの課題に直面しています。また、各地域における規制遵守の複雑さも市場拡大の障壁となっています。さらに、画像データの解釈や分析に熟練した専門家が不足しているため、効率的な臨床試験の実施が課題となっています。さらに、治験承認の遅れや治験実施施設ごとの画像診断プロトコルのばらつきが、この市場の運用上の複雑さに拍車をかけています。

臨床試験イメージング市場は、クラウドベースのイメージングソリューションとリモートモニタリング技術の採用増加により、大きな成長機会をもたらしています。AIを搭載した画像処理ソフトウェアの開発により、リアルタイムのデータ処理が強化され、画像解析が自動化されるため、人的ミスが減少すると期待されます。また、製薬会社、医薬品開発業務受託機関（CRO）、画像サービスプロバイダー間の戦略的提携により、臨床試験の画像処理ワークフローの合理化が進むと予想されます。新興市場、特にアジア太平洋地域における臨床試験の拡大は、市場プレーヤーに有利な成長見通しをもたらします。

当レポートでは、世界の臨床試験イメージング市場について調査し、製品・サービス別、モダリティ別、治療分野別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の範囲と定義
  • 市場力学
  • マクロ経済要因
  • COVID-19の影響分析
  • 予測要因- 関連性と影響

第3章 付加価値の洞察

第4章 価格動向分析、2019年～2032年

第5章 世界の臨床試験イメージング市場の見通し

  • 主なハイライト
  • 市場規模の分析と予測
    • 過去の市場規模分析、2019年～2024年
    • 現在の市場規模分析と予測、2025年～2032年
  • 世界の臨床試験イメージング市場の見通し：製品・サービス別
    • イントロダクション/主な調査結果
    • 過去の市場規模と数量（単位）分析、製品・サービス別、2019年～2024年
    • 現在の市場規模と数量（単位）分析と予測、製品・サービス別、2025年～2032年
  • 市場の魅力分析：製品・サービス別
  • 世界の臨床試験イメージング市場の見通し：モダリティ別
    • イントロダクション/主な調査結果
    • 過去の市場規模分析、モダリティ別、2019年～2024年
    • 現在の市場規模分析と予測、モダリティ別、2025年～2032年
  • 市場の魅力分析：モダリティ別
  • 世界の臨床試験イメージング市場の見通し：治療分野別
    • イントロダクション/主な調査結果
    • 過去の市場規模分析、治療分野別、2019年～2024年
    • 現在の市場規模分析と予測、治療分野別、2025年～2032年
  • 市場の魅力分析：治療領域
  • 世界の臨床試験イメージング市場の見通し：エンドユーザー別
    • イントロダクション/主な調査結果
    • 過去の市場規模と数量（単位）分析、エンドユーザー別、2019年～2024年
    • 現在の市場規模と数量（単位）分析と予測、エンドユーザー別、2025年～2032年

第6章 世界の臨床試験画像市場の見通し：地域別

  • 主なハイライト
  • 過去の市場規模と数量（単位）分析、地域別、2019年～2024年
  • 現在の市場規模と数量（単位）分析と予測、地域別、2025年～2032年
    • 北米
    • 欧州
    • 東アジア
    • 南アジアとオセアニア
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力分析：地域別

第7章 北米の臨床試験イメージング市場の見通し

第8章 欧州の臨床試験イメージング市場の見通し

第9章 東アジアの臨床試験イメージング市場の見通し

第10章 南アジアおよびオセアニアの臨床試験イメージング市場の見通し

第11章 ラテンアメリカの臨床試験イメージング市場の見通し

第12章 中東・アフリカの臨床試験イメージング市場の見通し

第13章 競合情勢

  • 市場シェア分析、2025年
  • 市場構造
  • 企業プロファイル（詳細- 概要、財務、戦略、最近の動向）
    • Ixico PLC
    • Navitas Life Sciences
    • Resonance Health
    • Radiant Sage LLC
    • Medpace
    • WCG Clinical
    • Icon PLC
    • Voiant
    • Clario
    • Parexel International Corporation
    • Anagram
    • Calyx
    • Invicro

第14章 付録

目次
Product Code: PMRREP35178

Persistence Market Research has recently released a comprehensive report on the worldwide market for clinical trial imaging. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global clinical trial imaging market from 2025 to 2032.

Key Insights:

  • Clinical Trial Imaging Market Size (2025E): US$ 1.5 Bn
  • Projected Market Value (2032F): US$ 2.5 Bn
  • Global Market Growth Rate (CAGR 2025 to 2032): 7.5%

Clinical Trial Imaging Market - Report Scope:

Clinical trial imaging refers to the use of medical imaging techniques such as MRI, CT scans, PET scans, and ultrasound in clinical trials to assess the efficacy and safety of new drugs, treatments, and medical devices. These imaging modalities help researchers in accurate disease diagnosis, treatment monitoring, and biomarker identification. The demand for clinical trial imaging is rising as pharmaceutical and biotechnology companies increasingly rely on imaging-based evidence to support regulatory approvals and accelerate drug development timelines.

Market Growth Drivers:

The global clinical trial imaging market is driven by several key factors, including the growing adoption of advanced imaging technologies in clinical research. The increasing prevalence of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions has fueled the demand for imaging-based biomarkers in drug trials. Moreover, the rising number of clinical trials globally, coupled with stringent regulatory requirements for imaging endpoints, is propelling market growth. Advancements in artificial intelligence (AI) and machine learning (ML) integration with imaging technologies are further enhancing image analysis accuracy, thus improving clinical trial outcomes.

Market Restraints:

Despite significant growth opportunities, the clinical trial imaging market faces challenges such as high costs associated with imaging modalities and infrastructure. The complexity of regulatory compliance in different regions also acts as a barrier to market expansion. Additionally, the shortage of skilled professionals for imaging data interpretation and analysis poses a challenge for efficient clinical trial execution. Delays in trial approvals and the variability in imaging protocols across different study sites further add to the operational complexities of this market.

Market Opportunities:

The clinical trial imaging market presents substantial growth opportunities driven by the increasing adoption of cloud-based imaging solutions and remote monitoring technologies. The development of AI-powered imaging software is expected to enhance real-time data processing and automate image analysis, reducing human errors. Additionally, strategic collaborations between pharmaceutical companies, contract research organizations (CROs), and imaging service providers are expected to streamline clinical trial imaging workflows. The expansion of clinical trials in emerging markets, particularly in Asia-Pacific, offers lucrative growth prospects for market players.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the clinical trial imaging market globally?
  • How does the integration of AI and machine learning enhance imaging capabilities in clinical trials?
  • Which therapeutic areas are leading in the adoption of clinical trial imaging solutions?
  • Who are the key players in the clinical trial imaging market, and what strategies are they employing to gain a competitive advantage?
  • What are the emerging trends and future growth prospects in the global clinical trial imaging market?

Competitive Intelligence and Business Strategy:

Leading players in the global clinical trial imaging market, including BioTelemetry, Parexel International Corporation, ICON plc, Medpace, and Biomedical Systems, focus on technological innovations, strategic partnerships, and service expansion to strengthen their market presence. Companies are investing in AI-driven imaging analysis platforms and cloud-based imaging solutions to improve clinical trial efficiency. Collaborations with pharmaceutical firms and CROs are facilitating the seamless integration of imaging endpoints in drug development studies. The increasing adoption of decentralized trials and remote imaging solutions is also shaping the future of clinical trial imaging, ensuring faster and more cost-effective trial execution.

Key Companies Profiled:

  • Ixico PLC
  • Navitas Life Sciences
  • Resonance Health
  • Radiant Sage LLC
  • Medpace
  • WCG Clinical
  • Icon PLC
  • Voiant
  • Clario
  • Parexel International Corporation
  • Anagram
  • Calyx
  • Invicro

Clinical Trial Imaging Market Segmentation

By Product & Services

  • Services
  • Software

By Modality

  • CT scan
  • MRI
  • X-Ray
  • Ultrasound

By Therapeutic Area

  • Oncology
  • Neurology
  • Cardiology
  • Orthopedics
  • Obstetrics & Gynecology

By End User

  • Contract Research Organizations (CROs)
  • Pharmaceutical & Biotechnology Companies
  • Academic and Government Research Institutes

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Clinical Trial Imaging Market Snapshot, 2025-2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product & Services Adoption Analysis
  • 3.2. Regulatory Landscape
  • 3.3. Value Chain Analysis
  • 3.4. Key Deals and Mergers
  • 3.5. PESTLE Analysis
  • 3.6. Porter's Five Force Analysis

4. Price Trend Analysis, 2019-2032

  • 4.1. Key Highlights
  • 4.2. Key Factors Impacting Product & Services Prices
  • 4.3. Pricing Analysis By Product & Services
  • 4.4. Regional Prices and Product & Services Preferences

5. Global Clinical Trial Imaging Market Outlook:

  • 5.1. Key Highlights
    • 5.1.1. Market Volume (Units) Projections
    • 5.1.2. Market Size (US$ Bn) and Y-o-Y Growth
    • 5.1.3. Absolute $ Opportunity
  • 5.2. Market Size (US$ Bn) Analysis and Forecast
    • 5.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
    • 5.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2025-2032
  • 5.3. Global Clinical Trial Imaging Market Outlook: Product & Services
    • 5.3.1. Introduction / Key Findings
    • 5.3.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Product & Services, 2019-2024
    • 5.3.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product & Services, 2025-2032
      • 5.3.3.1. Services
      • 5.3.3.2. Software
  • 5.4. Market Attractiveness Analysis: Product & Services
  • 5.5. Global Clinical Trial Imaging Market Outlook: Modality
    • 5.5.1. Introduction / Key Findings
    • 5.5.2. Historical Market Size (US$ Bn) Analysis, By Modality, 2019-2024
    • 5.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
      • 5.5.3.1. CT scan
      • 5.5.3.2. MRI
      • 5.5.3.3. X-Ray
  • 5.6. Market Attractiveness Analysis: Modality
  • 5.7. Global Clinical Trial Imaging Market Outlook: Therapeutic Area
    • 5.7.1. Introduction / Key Findings
    • 5.7.2. Historical Market Size (US$ Bn) Analysis, By Therapeutic Area, 2019-2024
    • 5.7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area, 2025-2032
      • 5.7.3.1. Oncology
      • 5.7.3.2. Neurology
      • 5.7.3.3. Cardiology
      • 5.7.3.4. Orthopedics
      • 5.7.3.5. Obstetrics & Gynecology
  • 5.8. Market Attractiveness Analysis: Therapeutic Area
  • 5.9. Global Clinical Trial Imaging Market Outlook: End User
    • 5.9.1. Introduction / Key Findings
    • 5.9.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By End User, 2019-2024
    • 5.9.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By End User, 2025-2032
      • 5.9.3.1. Contract Research Organizations (CROs)
      • 5.9.3.2. Pharmaceutical & Biotechnology Companies
      • 5.9.3.3. Academic and Government Research Institutes

6. Global Clinical Trial Imaging Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Region, 2019-2024
  • 6.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Region, 2025-2032
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia and Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Clinical Trial Imaging Market Outlook:

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2024
    • 7.2.1. By Country
    • 7.2.2. By Product & Services
    • 7.2.3. By Modality
    • 7.2.4. By Therapeutic Area
  • 7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product & Services, 2025-2032
    • 7.4.1. Services
    • 7.4.2. Software
  • 7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
    • 7.5.1. CT scan
    • 7.5.2. MRI
    • 7.5.3. X-Ray
  • 7.6. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area , 2025-2032
    • 7.6.1. Oncology
    • 7.6.2. Neurology
    • 7.6.3. Cardiology
    • 7.6.4. Orthopedics
    • 7.6.5. Obstetrics & Gynecology
  • 7.7. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By End User, 2025-2032
    • 7.7.1. Contract Research Organizations (CROs)
    • 7.7.2. Pharmaceutical & Biotechnology Companies
    • 7.7.3. Academic and Government Research Institutes
  • 7.8. Market Attractiveness Analysis

8. Europe Clinical Trial Imaging Market Outlook:

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2024
    • 8.2.1. By Country
    • 8.2.2. By Product & Services
    • 8.2.3. By Modality
    • 8.2.4. By Therapeutic Area
  • 8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. U.K.
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Russia
    • 8.3.7. Turkey
    • 8.3.8. Rest of Europe
  • 8.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product & Services, 2025-2032
    • 8.4.1. Services
    • 8.4.2. Software
  • 8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
    • 8.5.1. CT scan
    • 8.5.2. MRI
    • 8.5.3. X-Ray
  • 8.6. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area , 2025-2032
    • 8.6.1. Oncology
    • 8.6.2. Neurology
    • 8.6.3. Cardiology
    • 8.6.4. Orthopedics
    • 8.6.5. Obstetrics & Gynecology
  • 8.7. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By End User, 2025-2032
    • 8.7.1. Contract Research Organizations (CROs)
    • 8.7.2. Pharmaceutical & Biotechnology Companies
    • 8.7.3. Academic and Government Research Institutes
  • 8.8. Market Attractiveness Analysis

9. East Asia Clinical Trial Imaging Market Outlook:

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2024
    • 9.2.1. By Country
    • 9.2.2. By Product & Services
    • 9.2.3. By Modality
    • 9.2.4. By Therapeutic Area
  • 9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. South Korea
  • 9.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product & Services, 2025-2032
    • 9.4.1. Services
    • 9.4.2. Software
  • 9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
    • 9.5.1. CT scan
    • 9.5.2. MRI
    • 9.5.3. X-Ray
  • 9.6. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area , 2025-2032
    • 9.6.1. Oncology
    • 9.6.2. Neurology
    • 9.6.3. Cardiology
    • 9.6.4. Orthopedics
    • 9.6.5. Obstetrics & Gynecology
  • 9.7. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By End User, 2025-2032
    • 9.7.1. Contract Research Organizations (CROs)
    • 9.7.2. Pharmaceutical & Biotechnology Companies
    • 9.7.3. Academic and Government Research Institutes
  • 9.8. Market Attractiveness Analysis

10. South Asia & Oceania Clinical Trial Imaging Market Outlook:

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2024
    • 10.2.1. By Country
    • 10.2.2. By Product & Services
    • 10.2.3. By Modality
    • 10.2.4. By Therapeutic Area
  • 10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. India
    • 10.3.2. Southeast Asia
    • 10.3.3. ANZ
    • 10.3.4. Rest of South Asia & Oceania
  • 10.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product & Services, 2025-2032
    • 10.4.1. Services
    • 10.4.2. Software
  • 10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
    • 10.5.1. CT scan
    • 10.5.2. MRI
    • 10.5.3. X-Ray
  • 10.6. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area , 2025-2032
    • 10.6.1. Oncology
    • 10.6.2. Neurology
    • 10.6.3. Cardiology
    • 10.6.4. Orthopedics
    • 10.6.5. Obstetrics & Gynecology
  • 10.7. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By End User, 2025-2032
    • 10.7.1. Contract Research Organizations (CROs)
    • 10.7.2. Pharmaceutical & Biotechnology Companies
    • 10.7.3. Academic and Government Research Institutes
  • 10.8. Market Attractiveness Analysis

11. Latin America Clinical Trial Imaging Market Outlook:

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2024
    • 11.2.1. By Country
    • 11.2.2. By Product & Services
    • 11.2.3. By Modality
    • 11.2.4. By Therapeutic Area
  • 11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. Brazil
    • 11.3.2. Mexico
    • 11.3.3. Rest of Latin America
  • 11.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product & Services, 2025-2032
    • 11.4.1. Services
    • 11.4.2. Software
  • 11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
    • 11.5.1. CT scan
    • 11.5.2. MRI
    • 11.5.3. X-Ray
  • 11.6. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area , 2025-2032
    • 11.6.1. Oncology
    • 11.6.2. Neurology
    • 11.6.3. Cardiology
    • 11.6.4. Orthopedics
    • 11.6.5. Obstetrics & Gynecology
  • 11.7. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By End User, 2025-2032
    • 11.7.1. Contract Research Organizations (CROs)
    • 11.7.2. Pharmaceutical & Biotechnology Companies
    • 11.7.3. Academic and Government Research Institutes
  • 11.8. Market Attractiveness Analysis

12. Middle East & Africa Clinical Trial Imaging Market Outlook:

  • 12.1. Key Highlights
  • 12.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2024
    • 12.2.1. By Country
    • 12.2.2. By Product & Services
    • 12.2.3. By Modality
    • 12.2.4. By Therapeutic Area
  • 12.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 12.3.1. GCC Countries
    • 12.3.2. Egypt
    • 12.3.3. South Africa
    • 12.3.4. Northern Africa
    • 12.3.5. Rest of Middle East & Africa
  • 12.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product & Services, 2025-2032
    • 12.4.1. Services
    • 12.4.2. Software
  • 12.5. Current Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
    • 12.5.1. CT scan
    • 12.5.2. MRI
    • 12.5.3. X-Ray
  • 12.6. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area , 2025-2032
    • 12.6.1. Oncology
    • 12.6.2. Neurology
    • 12.6.3. Cardiology
    • 12.6.4. Orthopedics
    • 12.6.5. Obstetrics & Gynecology
  • 12.7. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By End User, 2025-2032
    • 12.7.1. Contract Research Organizations (CROs)
    • 12.7.2. Pharmaceutical & Biotechnology Companies
    • 12.7.3. Academic and Government Research Institutes
  • 12.8. Market Attractiveness Analysis

13. Competition Landscape

  • 13.1. Market Share Analysis, 2025
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping By Market
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.3.1. Ixico PLC
      • 13.3.1.1. Overview
      • 13.3.1.2. Segments and Product & Services Types
      • 13.3.1.3. Key Financials
      • 13.3.1.4. Market Developments
      • 13.3.1.5. Market Strategy
    • 13.3.2. Navitas Life Sciences
    • 13.3.3. Resonance Health
    • 13.3.4. Radiant Sage LLC
    • 13.3.5. Medpace
    • 13.3.6. WCG Clinical
    • 13.3.7. Icon PLC
    • 13.3.8. Voiant
    • 13.3.9. Clario
    • 13.3.10. Parexel International Corporation
    • 13.3.11. Anagram
    • 13.3.12. Calyx
    • 13.3.13. Invicro

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations